| pubmed-article:12528309 | pubmed:abstractText | Berlex (a Schering subsidiary) and Pfizer (formerly Parke-Davis) are developing ZK-807834 (CI-1031), one of a series of Factor Xa inhibitors, for the potential parenteral treatment of unstable angina pectoris. | lld:pubmed |
